Eaton Vance Management Vanda Pharmaceuticals Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $34,937 - $53,340	-3,223 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $1,569 - $2,114	100 Added 3.2%	3,223 $0
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $5,265 - $7,295	-343 Reduced 9.9%	3,123 $0
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $44,160 - $60,464	2,811 Added 429.16%	3,466 $75,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $8,790 - $13,283	655 New	655 $10,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.